This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1979;3(1):17-24.

doi: 10.1007/BF00254415.

Antibodies as specific carriers for chemotherapeutic agents

F H Lee, K M Hwang

PMID: 394875
DOI: 10.1007/BF00254415

Review

Antibodies as specific carriers for chemotherapeutic agents

F H Lee et al. Cancer Chemother Pharmacol. 1979.

. 1979;3(1):17-24.

doi: 10.1007/BF00254415.

Authors

F H Lee, K M Hwang

PMID: 394875
DOI: 10.1007/BF00254415

No abstract available

PubMed Disclaimer

Similar articles

Antibodies as carriers of anticancer agents.
Rubens RD. Rubens RD. Lancet. 1974 Mar 23;1(7856):498-9. doi: 10.1016/s0140-6736(74)92799-8. Lancet. 1974. PMID: 4131895 No abstract available.
Oncostatic-antibody complexes in chemotherapy.
Dullens HF, De Weger RA. Dullens HF, et al. Cancer Chemother Pharmacol. 1980;4(1):29-32. doi: 10.1007/BF00255454. Cancer Chemother Pharmacol. 1980. PMID: 6988099 Review.
Monoclonal antibodies for targeting chemotherapeutic agents.
Baldwin RW. Baldwin RW. Prog Exp Tumor Res. 1985;29:140-51. doi: 10.1159/000411634. Prog Exp Tumor Res. 1985. PMID: 4070629 No abstract available.
Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
Schlom J. Schlom J. Cancer Res. 1986 Jul;46(7):3225-38. Cancer Res. 1986. PMID: 3518915 Review. No abstract available.
[Novel monoclonal antibodies for the treatment of malignant lymphomas].
Maruyama D. Maruyama D. Rinsho Ketsueki. 2011 Aug;52(8):618-26. Rinsho Ketsueki. 2011. PMID: 21897067 Review. Japanese. No abstract available.

See all similar articles

Cited by

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.
Ford CH, Newman CE, Johnson JR, Woodhouse CS, Reeder TA, Rowland GF, Simmonds RG. Ford CH, et al. Br J Cancer. 1983 Jan;47(1):35-42. doi: 10.1038/bjc.1983.4. Br J Cancer. 1983. PMID: 6821632 Free PMC article.
Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat.
Falk RE, Hardy M, Makowka L, Teodorczyk-Injeyan J, Falk JA. Falk RE, et al. J Clin Invest. 1982 Sep;70(3):558-67. doi: 10.1172/jci110648. J Clin Invest. 1982. PMID: 7107895 Free PMC article.
The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.
Rowland AJ, Harper ME, Wilson DW, Griffiths K. Rowland AJ, et al. Br J Cancer. 1990 May;61(5):702-8. doi: 10.1038/bjc.1990.158. Br J Cancer. 1990. PMID: 2337507 Free PMC article.
A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.
Johnson JR, Ford CH, Newman CE, Woodhouse CS, Rowland GF, Simmonds RG. Johnson JR, et al. Br J Cancer. 1981 Sep;44(3):472-5. doi: 10.1038/bjc.1981.209. Br J Cancer. 1981. PMID: 7284242 Free PMC article. No abstract available.
Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.
Ford CH, Casson AG. Ford CH, et al. Cancer Chemother Pharmacol. 1986;17(3):197-208. doi: 10.1007/BF00256685. Cancer Chemother Pharmacol. 1986. PMID: 3527466 Review.

References

1. Int J Cancer. 1970 Mar 15;5(2):195-201 - PubMed
1. Nature. 1974 Mar 1;248(5443):81-2 - PubMed
1. Nature. 1977 May 5;267(5606):56-8 - PubMed
1. Eur J Cancer. 1977 Jun;13(6):593-6 - PubMed
1. J Natl Cancer Inst. 1974 May;52(5):1665-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database